Trial site
Mid-Atlantic Epilepsy and Sleep Center
- 6running trials
- 10closed trials
The trials here
What the 16 trials at this site are about, from their registry records.
- Conditions
- Epilepsy16 trials
- Phase
- Phase 39 trials
- Phase 25 trials
- Phase 11 trial
- Phase 1/21 trial
- Status
- Completed9 trials
- Recruiting4 trials
- Active, not recruiting1 trial
- Enrolling by invitation1 trial
- Withdrawn1 trial
- Lead sponsor
- SK Life Science, Inc.5 trials
- Xenon Pharmaceuticals Inc.5 trials
- Longboard Pharmaceuticals2 trials
- Engrail Therapeutics INC1 trial
- Janssen Research & Development, LLC1 trial
- and 2 more
Running trials
Recruiting
Recruiting
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
Enrolling by invitation
Recruiting
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
Recruiting
Active, not recruiting
A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Epilepsy5 recruiting
Closed trials
Completed
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures
Completed
Withdrawn
ENACT: A Study of ENX-101 as Adjunctive Treatment in Patients With Focal Seizures
Completed
Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy
Completed
Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies
Completed
Completed
Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures
Completed
A Study to Investigate JNJ-40411813 in Combination With Levetiracetam or Brivaracetam in Epilepsy
Completed
Completed
Site data: ClinicalTrials.govUpdated 16 Nov 2026